PEDV evades MHC-I-related immunity through nsp1-mediated NLRC5 translation inhibition. Liu X, Zhang M, Yin L, Kang L, et al. J Virol 2024 Oct 31:e0142124. doi: 10.1128/jvi.01421.

Read + Share

Amedeo Smart

Independent Medical Education

Liu X, Zhang M, Yin L, Kang L, et al. PEDV evades MHC-I-related immunity through nsp1-mediated NLRC5 translation inhibition. J Virol 2024 Oct 31:e0142124. doi: 10.1128/jvi.01421.
PMID: 39480087